Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation

Best Practice and Research: Clinical Haematology

Volumn 20, Issue 2, 2007, Pages 219-229

  Gahrton, Gösta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

allogeneic stem cell transplantation; donor recipient sex combination; graft rejection; graft versus host disease; graft versus tumor effect

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; CANCER REGISTRY; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DONOR; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; MALE; MEDICAL DOCUMENTATION; MORTALITY; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; T LYMPHOCYTE; Y CHROMOSOME;

ANEMIA, APLASTIC; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; RECURRENCE; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247166352     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2006.09.007     Document Type: Review

References (37)

1. Storb R., Prentice R.L., and Thomas E.D. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. The Journal of Clinical Investigation 59 (1977) 625-632
2. Eichwald E.J., and Silmser C.R. Skin. Transplantation Bulletin 2 (1955) 148-149
3. Goulmy E., Termijtelen A., Bradley B.A., et al. Alloimmunity to human H-Y. Lancet 2 (1976) 1206
4. Zwaan F., Gratwohl A., and Hermans J. The influence of donor-recipient sex mismatchingon on the outcome of allogeneic BMT in leukaemias. Bone Marrow Transplantation 4 (1989) 8
5. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352 (1998) 1087-1092
6. Randolph S.S., Gooley T.A., Warren E.H., et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103 (2004) 347-352
7. Gahrton G., Iacobelli S., Apperley J., et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplantation 35 (2005) 609-617
8. Stern M., Passweg J., Locasciulli A., et al. Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Transplantation 82 (2006) 218-226
9. Spierings E., Vermeulen C.J., Vogt M.H., et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362 (2003) 610-615
10. Weisdorf D., Hakke R., Blazar B., et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51 (1991) 1197-1203
11. Carlens S., Ringden O., Aschan J., et al. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination. Clinical Transplantation 12 (1998) 84-92
12. Gratwohl A.H.J., Niederwieser D., van Biezen A., et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. The Hematology Journal 2 (2001) 363-370
13. Gratwohl A., Brand R., Apperley J., et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 100 (2002) 3877-3886
14. Frassoni F., Labopin M., Gluckman E., et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time-a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplantation 17 (1996) 13-18
15. Kollman C., Howe C.W., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98 (2001) 2043-2051
16. Verdijk R.M., Kloosterman A., Pool J., et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103 (2004) 1961-1964
17. James E., Chai J.G., Dewchand H., et al. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 102 (2003) 388-393
18. Storb R., Prentice R.L., and Thomas E.D. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. The New England Journal of Medicine 296 (1977) 61-66
19. Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: a review. Journal of Women's Health 14 (2005) 617-626
20. Candinas D., Gunson B.K., Nightingale P., et al. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 346 (1995) 1117-1121
21. Rustgi V.K., Marino G., Halpern M.T., et al. Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transplantation 8 (2002) 514-518
22. Zeier M., Dohler B., Opelz G., et al. The effect of donor gender on graft survival. Journal of the American Society of Nephrology 13 (2002) 2570-2576
23. Neugarten J., and Silbiger S.R. The impact of gender on renal transplantation. Transplantation 58 (1994) 1145-1152
24. Weiden P.L., Sullivan K.M., Flournoy N., et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. The New England Journal of Medicine 304 (1981) 1529-1533
25. Horowitz M.M., Gale R.P., Sondel P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 (1990) 555-562
26. Kolb H.J., Schattenberg A., Goldman J.M., et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86 (1995) 2041-2050
27. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998) 756-763
28. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
29. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101 (2003) 1620-1629
30. Crawley C., Iacobelli I., Björkstrand B., et al. Reduced-intensity conditioning does not improve survival compared to standard conditioning for patients with myeloma. Bone Marrow Transplantation 35 (2005) S48
31. Bonnet D., Warren E.H., Greenberg P.D., et al. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proceedings of the National Academy of Sciences of the USA 96 (1999) 8639-8644
32. Warren E.H., Gavin M.A., Simpson E., et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. Journal of Immunology 164 (2000) 2807-2814
33. Wang W., Meadows L.R., den Haan J.M., et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269 (1995) 1588-1590
34. Meadows L., Wang W., den Haan J.M., et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6 (1997) 273-281
35. Vogt M.H., de Paus R.A., Voogt P.J., et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95 (2000) 1100-1105
36. Vogt M.H., Goulmy E., Kloosterboer F.M., et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96 (2000) 3126-3132
37. Vogt M.H., van den Muijsenberg J.W., Goulmy E., et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 99 (2002) 3027-3032